Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Eplerenone in Acute Myocardial Infarction Without Heart Failure
NCT01176968Phase 4Completed
- Sponsor
- Viatris
- Start
- Sep 2010
- Primary completion
- Oct 2012
- Modality
- Orthosteric Ligands
- Countries
- 11
01
Overview
Phase 4, randomised, double-blind trial in myocardial infarction (MI) comparing Eplerenone with Placebo (2 arms). Primary endpoint: First Event of Cardiovascular Mortality, Re-hospitalization or Extended Initial Hospital Stay Due to Diagnosis of Heart Failure, Sustained Ventricular Tachycardia or Fibrillation, Ejection Fraction… Started Sep 2010; status: completed.
02
Drugs
eplerenone
03
Conditions
myocardial infarction (MI)
Beyond the preview
Go deeper on NCT01176968.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01176968.